Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma
- PMID: 15798466
- PMCID: PMC1357068
- DOI: 10.1097/01.sla.0000157317.60536.08
Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma
Abstract
Objective: To conduct a retrospective study of 39 patients with papillary carcinoma of the thyroid with histologic vascular invasion (VI+) and 361 patients without any sign of vascular invasion (VI-).
Summary background data: In the present study, we undertook a retrospective analysis of papillary carcinoma of the thyroid to assess whether histologically determined vascular invasion can be considered a predictive factor for prognosis.
Methods: By means of a retrospective study, we evaluated the department's database of patients with papillary thyroid carcinoma who had undergone total thyroidectomy from January 1993 to December 1999.
Results: Group I consisted of papillary carcinoma without any sign of vascular invasion (VI-) comprising 361 patients. Group II consisted of papillary carcinoma with vascular invasion (VI+) comprising 39 patients. At the time of diagnosis, we observed no metastases in patients with VI-, whereas a pulmonary metastasis was observed in 1 patient with VI+ (P = 0.0023). In 3.6% patients with VI- and in 20.5% patients with VI+, we observed recurrences in the regional lymph nodes (P < 0.001); we observed 6 (1.66%) distant metastases in patients with VI- and in the 12.8% patients with VI+ (P < 0.001). Three patients with VI+ (7.7%) and 2 patients with VI- (0.6%) died of tumor-related causes; these figures were found to be statistically significant (P < 0.001).
Conclusions: In papillary carcinoma, it should be noted that histologic vascular invasion may be considered as a sign of an increased tendency toward hematogenic invasion and consequent increase in the relative percentage of metastases; ultimately, this means a poorer prognosis. In the presence of risk factors indicating a possible increase in biologic aggressiveness, adequate postoperative treatment and close follow up become essential.
Figures
Similar articles
-
Prognostic importance of sclerosing variant in papillary thyroid carcinoma.Am Surg. 2006 May;72(5):438-44. Am Surg. 2006. PMID: 16719201
-
Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.Ann Surg. 2005 Nov;242(5):708-15. doi: 10.1097/01.sla.0000186421.30982.d2. Ann Surg. 2005. PMID: 16244545 Free PMC article.
-
Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study.J Clin Pathol. 2016 Oct;69(10):872-7. doi: 10.1136/jclinpath-2015-203547. Epub 2016 Mar 24. J Clin Pathol. 2016. PMID: 27010434
-
Peroperative diagnosis and treatment of metastases to the regional lymph nodes in papillary carcinoma of the thyroid gland.Surg Gynecol Obstet. 1989 Aug;169(2):107-14. Surg Gynecol Obstet. 1989. PMID: 2667172 Review.
-
Thyroid surgery for differentiated thyroid cancer - recent advances and future directions.Nat Rev Endocrinol. 2018 Nov;14(11):670-683. doi: 10.1038/s41574-018-0080-7. Nat Rev Endocrinol. 2018. PMID: 30131586 Review.
Cited by
-
Noninferior response in BRAF(V600E) mutant nonmetastatic papillary thyroid carcinoma to radioiodine therapy.Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1034-9. doi: 10.1007/s00259-015-3305-1. Epub 2016 Jan 16. Eur J Nucl Med Mol Imaging. 2016. PMID: 26780618
-
Early Dynamic Risk Stratification Decreases Rate of Ablative and Adjuvant Radioiodine Use in ATA Low and Intermediate Risk Papillary Thyroid Cancer Patients.Sisli Etfal Hastan Tip Bul. 2023 Dec 29;57(4):451-457. doi: 10.14744/SEMB.2023.97415. eCollection 2023. Sisli Etfal Hastan Tip Bul. 2023. PMID: 38268648 Free PMC article.
-
Predictive factors for lateral occult lymph node metastasis in papillary thyroid carcinoma.Eur Arch Otorhinolaryngol. 2013 Jul;270(7):2095-100. doi: 10.1007/s00405-012-2305-z. Epub 2012 Dec 13. Eur Arch Otorhinolaryngol. 2013. PMID: 23238703
-
Prognostic values of thyroid tumours.Bosn J Basic Med Sci. 2009 May;9(2):111-9. doi: 10.17305/bjbms.2009.2829. Bosn J Basic Med Sci. 2009. PMID: 19485942 Free PMC article.
-
Disease-free Survival of Patients with Differentiated Thyroid Cancer: A Study from a Tertiary Center in Oman.Oman Med J. 2021 Mar 31;36(2):e246. doi: 10.5001/omj.2021.54. eCollection 2021 Mar. Oman Med J. 2021. PMID: 33854795 Free PMC article.
References
-
- Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma. A study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer. 1979;15:1033–1041. - PubMed
-
- Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer. 1985;55:794–804. - PubMed
-
- Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery. 1987;102:1088–1095. - PubMed
-
- Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947–953. - PubMed
-
- Gardner RE, Tuttle RM, Burman KD, et al. Prognostic importance of vascular invasion in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2000;126:309–312. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical